Fig. 3From: Effect of long-acting erythropoiesis-stimulating agents on hemoglobin levels at the initiation of dialysisThe Hb level of patients who received long-acting ESA was significantly higher than in the patients who received no ESA (P < 0.001) or short-acting ESA (P < 0.001). There was no significant difference in Hb levels between the non-ESA and short-acting ESA patient groupsBack to article page